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Abstract
Nisin is a 34-residue-long peptide belonging to the group A lantibiotics with antimicrobial activity against Gram-positive
bacteria. The presence of dehydrated residues and lanthionine rings (thioether bonds) in nisin, imposing structural restrains
on the peptide, make it an interesting case for studying the mode of action. In addition, the relatively high activity (nM range)
of nisin against Gram-positive bacteria indicates that nisin may be a special case in the large family of pore-forming peptides
antibiotics. In this review, we attempted to dissect the mode of action of nisin concentrating on studies that used model
membranes or biological membranes. The picture that emerges suggests that in model membrane systems, composed of only
phospholipids, nisin behaves similar to the antimicrobial peptide magainin, albeit with an activity that is much lower as
compared to its activity towards biological membranes. This difference can be contributed to a missing factor which nisin
needs for its high activity. Novel results have identified the factor as Lipid II, a precursor in the bacterial cell wall synthesis.
The special high affinity interaction of nisin with Lipid II resulting in high activity and the active role of Lipid II in the pore-
formation process make nisin a special case. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Of all the antimicrobial peptides known, only a
very few of them are actually allowed to be used
either as a preservative in the food industry or as
an antibiotic in health care. The 34-residue-long pep-
tide nisin is one of these few, and has been used as a
food preservative for a long time. It is part of the
family of lantibiotics (lanthionine-containing antibi-
otics), which are modi¢ed peptides, and are divided
into two groups, the elongated type A group and the
globular type B group (for reviews see [1^3]). Of the
latter group, it is believed that they predominantly
inhibit enzyme reactions. Nisin is part of the type A
group. The peptide shares similar characteristics with
other antimicrobial peptides. It is overall positively
charged (+4) and its structure possesses amphipathic
properties. However, some structural properties
make nisin rather special. Nisin is post-translation-
ally modi¢ed such that serine and threonine residues
are dehydrated to become dehydroalanine and dehy-
drobutyrine. Subsequently, ¢ve of the dehydrated
residues are coupled to upstream cysteines, thus
forming the thioether bonds that produce the char-
acteristic lanthionine rings (Fig. 1). Two naturally
occurring nisin variants that have similar activities,
nisin A and nisin Z, have been found [4,5]. Nisin A
di¡ers from nisin Z in a single amino acid residue at
position 27, being a histidine in nisin A and an as-
paragine in nisin Z [4]. The studies described in this
review were done either with nisin A or Z. Since
there is no di¡erence in activities between the two
peptides, this review will not discriminate between
the two peptides and mainly use the term nisin.
The thioether bonds give nisin two rigid ring systems,
one N-terminally and one C-terminally located. A
hinge region (residues 20^22), that often is found in
antimicrobial peptides, separates the ring systems.
Due to the ring structures, the nisin molecule is
maintained in a screw-like conformation that pos-
sesses amphipathic characteristics in two ways: the
N-terminal half of nisin is more hydrophobic than
the C-terminal half ; and the hydrophobic residues
are located at the opposite side of the hydrophilic
residues throughout the screw-like structure of the
nisin molecule. Therefore, in contrast to the peptides
described in this issue that adopt most of their (am-
phipathic, K-helical) structure only upon interaction
with membranes, nisin already possesses a fair
amount of structure in the aqueous phase. Only
slight variations in the conformations of the N-ter-
minus and the C-terminal ¢ve residues are observed
upon binding to membrane-mimicking micelles [6,7].
Nisin kills its target by pore formation in the tar-
get membrane. Over the past 10 years, much insight
into the mechanism of pore formation has been
achieved (see [1,3,8]). This review will focus on the
interactions of nisin with model and biological mem-
branes, and the attempts that have been made to
elucidate its mode of action. It will be divided into
di¡erent sections that deal with the interaction of
nisin with model and biological membranes. The
last part of the review will focus on a recent discov-
ery of great importance for understanding the mech-
anism of action.
2. The interaction of nisin with biological membranes
Nisin is predominantly active against Gram-posi-
tive bacteria. Only in conjunction with chemically
induced damage of the outer membrane can it also
act against Gram-negative bacteria, such as Escher-
ichia coli or Salmonella species. Initially, the antimi-
crobial activity of nisin was thought to be caused by
reacting with sulfhydryl groups of enzymes via the
dehydro residues [9] or by inhibition of cell wall syn-
thesis [10,11]. However, experiments with intact bac-
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terial cells and isolated plasma membrane vesicles
have shown that treatment of nisin resulted in rapid
e¥ux of small cytoplasmic compounds, e.g. amino
acids, ATP, or pre-accumulated rubidium [12,13]. It
is therefore now generally accepted that the bacterial
plasma membrane is the target for nisin, and that
nisin kills the cells by pore formation. The pore for-
mation causes collapse of vital ion gradients and
concomitant dissipation of the proton motive force
of the bacteria, resulting in cell death.
3. The interaction of nisin with model membrane
systems
Insight into the molecular aspects of pore forma-
tion by nisin has been obtained by using model sys-
tems. The ¢rst group to show that nisin can per-
meabilize model membranes composed of only
phospholipids was the group of Sahl [14]. They
showed that nisin at a peptide/lipid molar ratio
above 1:20 could permeabilize membranes composed
of the zwitterionic phospholipid DOPC. The posi-
tively charged nature of nisin would suggest that it
should interact preferably with anionic lipids. In-
deed, several studies indicated that nisin binds e⁄-
ciently to membranes containing anionic lipids [14^
18]. Surprisingly, in early studies, no leakage could
be detected from membranes containing negatively
charged lipids [14,17,19]. The anionic lipids even
seemed to inhibit dye leakage from vesicles. Studies
that are more recent gave a very di¡erent picture.
E⁄cient dye leakage could only be detected in the
presence of anionic lipids [15,18,20,21]. In addition,
the activity against isolated bacterial membrane
vesicles was strongly dependent on the presence of
anionic lipids [15]. The reason for this discrepancy
remains a mystery.
The mechanism leading to pore formation by nisin
can be divided into di¡erent steps. Obviously, the
¢rst step is binding to the target membrane, most
likely followed by insertion into the lipid phase of
the membrane. This insertion step will ¢nally lead
to pore formation. We will discuss the interaction
of nisin with model membranes further according
to these steps.
3.1. Nisin binding
The basic character of nisin suggests that it pref-
erably interacts with negatively charged membranes.
Indeed, every group that has studied the binding of
nisin to model membranes has shown that nisin
binds preferably to membranes containing anionic
lipids. The binding of nisin has been studied with
varying methods. Most studies used indirect methods
to measure nisin binding [14,17,18,22,23]. Two
groups used direct methods based on centrifugation
of lipid vesicles to separate membrane-bound pepti-
des from free [15,16]. Only one study systematically
varied the anionic lipid content of the membranes
[15]. It was shown that beyond an anionic lipid con-
tent of 40%, the amount of bound nisin increased
dramatically (Fig. 2). This suggests that nisin needs
a relatively large amount of anionic lipids for e⁄-
cient binding. In general, Gram-positive bacteria
have relative higher concentrations of anionic lipid
in their plasma membrane as compared to Gram-
Fig. 1. The primary structure of nisin Z. The typical residues found in lanthionins are dark gray for lanthionine residues and light
gray for dehydrated residues. Dha, dehydroalanine; Dhb, dehydrobutyrine, Ala^S^Ala, lanthionine; Abu^S^Ala, L-methyllanthionine.
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negative species [24]. Thus, this may partly explain
the higher activity of nisin towards Gram-positive
bacteria [15].
The binding isotherms of nisin displayed a bipha-
sic character, suggesting a cooperative interaction
[15]. Recent isothermal titration calorimetry (ITC)
experiments showed that binding of nisin to
DOPC/DOPG (3:1) membranes at low concentra-
tions is largely determined by the surface charge
(E. Breukink, J. Seelig and B. de Kruij¡, unpublished
observations). The intrinsic binding constant of nisin
was about a factor of 10 lower than that of magainin
[25]. This is in accordance with the relative activity of
the two peptides in dye-leakage assays using model
membranes of di¡erent composition (see Section 4).
Very useful information about the structural ele-
ments in nisin which are responsible for membrane
binding came from studies using nisin variants de-
rived by mutagenesis or chemical modi¢cation
[15,18,23] or fragments of nisin [18]. Changes in the
C-terminus had severe e¡ects on the nisin binding.
Introducing a negatively charged residue in the C-
terminus on position 32 of nisin almost completely
abolished the anionic lipid-dependent binding of ni-
sin (Fig. 2) [15]. The apparent binding constant for
this variant was also dramatically lowered as com-
pared to wild-type nisin in ITC experiments (E.
Breukink, J. Seelig and B. de Kruij¡, unpublished
observations). Fragments of the N-terminus of nisin
(N1^12 and N1^20) displayed hardly any a⁄nity for
membranes as compared to full-length nisin [18]. In
contrast to the large e¡ects on nisin binding by
changes in, or complete removal of the C-terminus,
changes in the N-terminus had only minor e¡ects.
Even the loss of a positive charge by replacement
of lysine-12 by a leucine residue did not e¡ect the
initial interaction of nisin with the membrane [18].
A major change that resulted in opening of the ¢rst
lanthionine ring and concomitant loss of activity also
hardly a¡ected the binding of this variant [23]. To-
gether, these results show that the C-terminus plays
an important role in the binding of nisin to the target
membrane by mediating the initial electrostatic inter-
action of nisin with the membrane. The results de-
scribed above would suggest that one could increase
the activity of nisin simply by increasing the positive
charge of the C-terminus. However, this is not the
case, since increasing the positive charge at the C-
terminus by replacing valine at position 32 with ly-
sine did not increase antibacterial activity [26],
although the a⁄nity of this mutant for membranes
containing anionic lipids was increased compared to
wild-type nisin (E. Breukink, J. Seelig and B. de
Kruij¡, unpublished observations). Moreover, add-
ing more positive charges to the C-terminus even
appeared to be detrimental for the activity of nisin
[27] (see Section 3.3).
3.2. Nisin insertion and orientation
After binding of nisin to the membrane, the am-
phiphilic properties of the peptide allow it to insert
into the lipid phase of the membrane. This insertion
step has been studied using the monolayer technique
[15,28], and quenching by depth probes of the £uo-
rescence of tryptophan variants of nisin [20,29]. The
monolayer studies showed that the presence of
anionic phospholipids was essential for e⁄cient in-
sertion of nisin in the lipid phase of the membrane.
Nisin variants with either extensions at the N-termi-
nus, or with minor changes in the ¢rst ring, displayed
severely reduced abilities to insert into lipid mono-
layers. In contrast, changes in the C-terminus hardly
a¡ected the ability of nisin to insert into the lipid
phase of the membrane [15,27]. These results indicate
that primarily the N-terminal part of nisin inserts
into the lipid phase of the membrane. Calculation
of the molecular hydrophobicity potential [30] of ni-
sin shows that the N-terminus of the peptide is the
Fig. 2. Binding of nisin Z (E) and [Glu-32]-nisin Z (a) to lipid
vesicles with di¡erent DOPG/DOPC ratios at a constant nisin:
phospholipid molar ratio of 1:25. Data were redrawn from [15].
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most hydrophobic (Fig. 3), suggesting that hydro-
phobic interactions are predominantly responsible
for insertion of the N-terminus of nisin into the lipid
phase of the membrane [31].
These conclusions were supported by experiments
using variants containing unique tryptophan residues
at three positions (1, 17 and 32) in the molecule. By
measuring the tryptophan £uorescence quenching by
spin-labeled lipids, the position of the three trypto-
phan residues in the membrane was determined. It
was shown that the tryptophan at the N-terminus
had the deepest location in the membrane, while
the C-terminal tryptophan was located close to the
membrane surface. Moreover, it became clear that an
increase in the amount of anionic lipids resulted in
an increased depth of insertion of the nisin molecule.
With the information on the depth of the tryptophan
residues and the NMR structure of nisin [6], it be-
came possible to estimate the orientation of nisin in
the membrane (Fig. 4) [29]. As can be seen from this
¢gure, the N-terminus is more deeply inserted than
the C-terminus, while the peptide has an overall par-
allel orientation towards the membrane surface.
However, from experiments using one variant of ni-
sin possessing a tryptophan at position 30, it was
concluded that the C-terminus inserted deeper into
the membrane as compared to the N-terminus [20].
This is not consistent with the picture presented in
Fig. 4 and therefore we propose another interpreta-
tion of these results. When a tryptophan residue is
placed at position 30 in the structure of nisin as
shown in Fig. 4, it indeed possesses a deep location
in the bilayer, in agreement with the results of Mar-
tin et al. [20]. Thus, this residue is not deeply inserted
into the bilayer due to deep insertion of the complete
C-terminus, but merely possesses a relative deeper
location in a nisin molecule, which maintains its
overall parallel orientation to the bilayer. This shows
the importance of using multiple tryptophans for
these kind of experiments. Interestingly, with a to-
tally independent approach using molecular dynam-
ics calculations of nisin structures in a simulated bi-
layer interface, an orientation was predicted similar
to that presented in Fig. 4 [31]. In conclusion, the
stable orientation of nisin in the membrane is parallel
with respect to the membrane surface.
3.3. Pore formation by nisin
Pore formation by nisin is most likely a coopera-
Fig. 3. Molecular hydrophobicity potential (MHP) around nisin which is represented in CPK. Green envelopes represent hydrophilic
potentials and orange/brown envelopes, the hydrophobic ones. Figure adapted from Lins et al. [31].
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tive process, which is preceded and/or accompanied
by aggregation of peptides in the membrane. In sev-
eral studies, evidence for aggregation of nisin in the
membrane was found. The shape of the binding iso-
therms of nisin in the presence of anionic lipid-con-
taining membranes were indicative of a process
where the peptides aggregate once inside the mem-
brane [15]. The £uorescence of the tryptophan var-
iants of nisin displayed self-quenching most likely
caused by aggregation of the peptides [29]. Results
from planar lipid bilayer studies also suggested that
aggregation of nisin monomers occurred in the mem-
brane [22].
The actual pore formation by nisin was studied
with dye-leakage assays that showed a strong de-
pendency of the membrane permeabilizing activity
of nisin on the presence of negatively charged lipids
[15,18,20]. It seems that the anionic lipids promote
the nisin activity independent of the headgroup type,
since DOPS [18], cardiolipin [18,20] as well as DOPG
[15], all promoted the nisin activity in leakage assays
using calcein- [18,20] or carboxy£uorescein-based
[15] leakage assays. The nisin-induced leakage of car-
boxy£uorescein from mixed DOPG/DOPC vesicles,
displayed a similar dependency on the amount of
DOPG present as was observed for the binding
(compare Figs. 2 and 5). This suggests that the
amount of bound nisin greatly in£uences the amount
of leakage that occurs.
Only limited information about the pore state of
nisin is available. The size of the nisin pore, esti-
mated from black-lipid membrane experiments, was
1 nm [32]. From the preferential release of the neg-
atively charged carboxy£uorescein over the positively
charged potassium ion, it was proposed that nisin is
anion-selective [15]. It was suggested that this is due
to the alignment of positively charged residues in the
nisin pore. Support for this comes from studies with
a nisin variant in which lysine-12 was replaced by a
leucine residue. The increased conductance and the
decreased dependence on the polarity of the applied
potential of pores produced by this variant caused
the authors to suggest that the lysine at position 12
controls the £ow of ions through the bilayer [18].
The £uorescence experiments discussed above in-
dicated that nisin had an overall stable orientation,
parallel with respect to the membrane surface. This
seems to contradict the existence of a nisin pore, in
which the nisin monomers possess a transmembrane
orientation. Thus, it seems plausible to suggest that
nisin permeabilizes the membrane due to local dis-
turbance of the bilayer. Evidence against this sugges-
tion came from recent experiments which showed
that nisin-induced leakage is paralleled by transloca-
tion of its C-terminus across the membrane [27].
Hence, nisin must have obtained a transmembrane
orientation at some point in time causing leakage
of ions. To reconcile these two results, one has to
Fig. 4. Modelling of the orientation of nisin in the membrane. Shown are backbone tracings of the nisin structure in the presence of
50% PG (A) and 90% PG (B), showing only the tryptophan and lysine residues. A and B are views along the peptide axis. The larger
dots in the tryptophan rings represent the centers of gravity of the tryptophan side chains which were used to position the trypto-
phans at their respective distance from the bilayer center (solid line). The dashed line represents the lipid^water interface. The trypto-
phan at position 30 in (B) was placed in the peptide structure after orientation of the peptide according to the depth pro¢le of the
other tryptophan residues, see text for further details. Figure adapted from [29].
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assume that the nisin pore is of transient nature. This
is in accordance with the short pore-lifetime of nisin
in black-lipid membrane experiments, which is in the
millisecond range [33].
A transient pore, together with translocation of
the C-terminus suggests that nisin has the same
mode of action (at least in phospholipid model mem-
brane systems) as magainin, an antimicrobial peptide
of animal origin. For this peptide, it was shown that
it also forms transient pores and upon relaxation of
the pore the peptide translocates in total to the inner
lea£et of the membrane [34,35]. For nisin, it was only
shown that the C-terminus translocates across the
membrane upon pore formation. However, due to
the relatively high concentration of peptides on the
outer lea£et, it is unlikely that the peptides £ip back
to this lea£et upon relaxation of the pore. Rather,
the peptides translocate completely relieving the
stress on the outer lea£et.
It was suggested that phospholipids are active
members of the pores formed by magainin [36]. Mag-
ainin pores are formed by both peptides and lipids,
and resemble a torus, in which the outer monolayer
of the membrane folds back to the inner monolayer.
It could be calculated that the lipids in the pore
possess an overall positive curvature [37]. It is possi-
ble that nisin possesses a similar pore structure.
However, direct experimental evidence is lacking.
Moreover, recent experiments using 31P-NMR magic
angle spinning (MAS) of phospholipid bilayers and
wideline 2H-NMR demonstrated that all the lipid
molecules in the system were in a bilayer phase
[38]. Interestingly, this study also demonstrated that
nisin can selectively recruit the negatively charged
lipid PG, which causes the lipid environment of nisin
to be enriched in PG as compared to the overall lipid
composition. This suggests that the negatively
charged lipids in the membrane play a more active
role than just providing binding sites.
3.4. The membrane potential
Nisin was shown to be less active against de-ener-
gized cells [12]. For instance, nisin could totally dis-
sipate the membrane potential of S. cohnii cells
which were fully energized, while it could only par-
tially dissipate the membrane potential of starved
cells. In addition, the activity of nisin against intact
cells of S. simulans seemed to depend on the magni-
tude of the membrane potential [33]. It was therefore
proposed that nisin needs an energized membrane for
its activity. From experiments with isolated mem-
brane vesicles similar conclusions were drawn [12,39].
In conjunction with the experiments with intact
bacteria, nisin activity was dependent on the applied
potential in model membrane experiments [17,19,32,
33,40]. These experiments showed that a threshold
potential was needed before any nisin activity could
be measured [33]. The threshold potential was de-
pendent on the amount of anionic lipids present
[32]. Opposing membrane potentials inhibited the ni-
sin activity [17,33].
Later studies also showed an e¡ect of the presence
of a membrane potential on nisin activity towards
model membrane vesicles [15]. However, in the pres-
ence of high amounts of anionic lipids, nisin could
e⁄ciently induce dye leakage from vesicles in the
absence of a membrane potential.
The action of the membrane potential is most
likely in the initial stages of the pore formation. It
probably acts via an electrophoretic action on the
charges of nisin to pull it into the membrane, result-
ing eventually in a transmembrane orientation. In
view of the above results on the insertion of the N-
terminus of nisin, the membrane potential probably
acts on the N-terminal positive charges, i.e. the N-
terminus and lysine at position 12. In e¡ect, the
membrane potential lowers the energy barrier for
pore formation. Support for this suggestion came
Fig. 5. The initial rate of nisin induced carboxy£uorescein leak-
age from vesicles with di¡erent DOPC/DOPG ratios. Nisin Z
(E), and [Glu-32]-nisin Z (a). Data redrawn from [15].
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from studies using a nisin variant in which the lysine
at position 12 was replaced by a leucine (K12L) [18].
This variant displayed no dependency on a threshold
potential, which is most likely caused by the replace-
ment of the positive charged residue in the N-termi-
nus by a hydrophobic residue facilitating the inser-
tion of nisin.
3.5. Model of the pore formation by nisin in lipid
bilayers
A general model can be build up which describes
the mechanism of action of nisin as deduced from
model membrane experiments. Nisin ¢rst binds
with its C-terminus via electrostatic interactions
with the anionic lipids (Fig. 6, step I). This is then
followed by dipping of the N-terminus into the lipid
phase of the membrane, and the peptide adopts an
overall parallel orientation with respect to the mem-
brane surface (step II). Upon insertion into the mem-
brane, nisin may locally disturb the phospholipids in
such a way that it induces a positive interface curva-
ture, especially in the presence of PG. In addition,
nisin recruits negatively charged lipids, thus creating
a locally higher concentration of these lipids in its
surrounding area.
Previously, it has been proposed that nisin follows
the barrel-stave model of pore formation [13,41]. In
this model, peptides ¢rst adopt a transmembrane
orientation before they aggregate to form water ¢lled
pores. As was correctly stated by Sahl [13], this
would imply exposure of charged groups in the lipid
phase of the bilayer, which is energetically highly
unfavorable. Therefore, it is more likely that several
(probably 4^6) peptides adopt a transmembrane ori-
entation in a cooperative manner, probably involving
pre-aggregation (although this remains to be re-
solved) of the peptides at the surface of the bilayer.
Taking into consideration the deeper insertion of the
N-terminus of nisin, it is tempting to speculate that
initiation of pore formation results in translocation
of the N-terminus to the inner lea£et of the mem-
brane. Thus, nisin forms pores in which the N-termi-
ni are located on the trans side with respect to the
side of addition (step III). Whether or not phospho-
lipids are active members of the pore remains to be
determined. The so-formed pore is not stable, and
will fall apart (as can be concluded from the life
Fig. 6. Model for the mode of action of nisin. Binding of nisin via its C-terminus (step I), insertion of nisin into the membrane (step
II), pore formation by nisin (step IV) in which the right part represents the situation when phospholipids are active members of the
pore, and translocation of the whole peptide (step IV).
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time described above). The relatively high peptide
concentration on the outer lea£et of the bilayer will
drive the relaxation of the pore towards the inner
lea£et of the bilayer. In e¡ect, the whole peptide
might translocate during pore relaxation (step IV).
4. What makes nisin a special case?
The above-described model for the mechanism of
action of nisin resembles the model for the mode of
action proposed for the antimicrobial peptide mag-
ainin [36]. The similar characteristics of nisin as com-
pared to magainin and related peptides, i.e. the pos-
itive charge and amphiphilic properties, probably
account for these similar modes of action. When
the activity of nisin is compared to the activity of
magainin towards model membrane systems in dye-
leakage experiments, the latter is even more active
(Fig. 7A). This is actually in correspondence to the
higher intrinsic binding constant of magainin as men-
tioned above. This raises the question of what the
advantages are of the special structural elements
that nisin possesses? This becomes evident when
the activities of the two peptides against Gram-pos-
itive bacteria are compared. In MIC-value determi-
nations, nisin is generally a factor 100^1000 more
active than magainin against, e.g. micrococci, strep-
tococci and staphylococci. Moreover, when the abil-
ity of the two peptides to dissipate the membrane
potential of intact M. £avus bacteria was tested, nisin
also displayed a factor of 1000 higher activity (Fig.
7B, Breukink et al. unpublished observations). These
activities of nisin are in the nM range, while its ac-
tivity in the model membrane systems described
above are in the WM range. Apparently, the nisin
activity towards intact bacteria is two to three orders
of magnitude higher, which is not accounted for by
an interaction solely with the phospholipids of the
target membrane. Thus, there must be a factor
present in the target membrane which somehow dra-
matically increases the nisin activity.
Indications about the identity of the unknown fac-
tor came from earlier studies which suggested that
nisin inhibited the cell wall synthesis [11]. In agree-
ment with this suggestion, it was later found that
nisin binds to Lipid II, a membrane-bound precursor
in peptidoglycan synthesis [10]. However, inhibition
of cell wall synthesis by nisin, like the formation of
pores in model systems, was only detected at concen-
trations well above the MIC-values of the respective
strains. Therefore, it was suggested that Lipid II
might somehow participate in pore formation by ni-
sin [12].
Lipid II is composed of a membrane anchor of 11
polyisoprene residues (undecaprenyl) to which, via a
pyrophosphate, the basic building block of the cell
wall, MurNAc(pentapeptide)-GlcNAc, is attached
(Fig. 8). Lipid II is synthesized on the cytosolic
Fig. 7. (A) Activity of nisin and magainin towards model mem-
branes composed of a lipid extract from M. £avus. The peptide
activity was measured by monitoring the leakage of carboxy-
£uorescein from vesicles made from a lipid extract of M. £avus
by measuring the increase in £uorescence due to dilution of the
dye from self-quenching concentrations as described [15]. The
concentration of both nisin and magainin was 2.5 WM. The ar-
rowheads mark the time point of peptide addition. (B) Activity
of nisin and magainin towards intact M. £avus cells. The pep-
tide activity was measured by monitoring their e¡ect on the
membrane potential with the £uorescent membrane-potential-
sensitive probe 3,3P-diethylthiodicarbocyanine iodide [DiS-C2(5)]
[50]. Cells were grown until midlog phase, harvested, and
washed once with 250 mM sucrose, 5 mM MgSO4, 10 mM po-
tassium-phosphate pH 7.0 and resuspended in the same bu¡er.
Cells were added to the £uorescence cuvette at a cell density of
OD600 = 0.075 together with DiS-C2(5) at 1 WM.
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side of the plasma membrane via addition of ¢rst the
UDP-activated amino sugar MurNAc(pentapeptide)
to undecaprenylphosphate (step a). This product is
called Lipid I. Then the second UDP-activated ami-
no sugar GlcNAc is attached, resulting in the com-
plete Lipid II molecule (step b). Subsequently Lipid
II somehow £ips to the exterior side of the plasma
membrane (step c), a process that is proposed to
involve a speci¢c membrane transporter. The two
amino sugars, including the pentapeptide, are then
coupled to the cell wall (step d). The remaining un-
decaprenylpyrophosphate is transported back to the
cytosolic side of the membrane (step e) where it is
dephosphorylated to undecaprenylphosphate (step f),
and the cycle can start again. It should be empha-
sized that several steps in this cycle require energy
input. For instance, the additions of amino acids to
the UDP-MurNAc to form the pentapeptide are
ATP-dependent steps [42,43]. In addition, the trans-
location of Lipid II across the membrane most likely
requires energy input, since related transport mecha-
nisms also using the undecaprenol carrier were highly
dependent on the proton motive force and a high
energy phosphate pool [44,45].
Only recently, it could be shown that Lipid II is
indeed an important factor in the pore formation by
nisin [46]. When the Lipid II biosynthesis was
blocked by ramoplanin, which inhibits step b in
Fig. 8 [47], the nisin sensitivity of intact cells de-
creased. Moreover, nisin-induced carboxy£uorescein
leakage from multilamellar liposomes was dramati-
cally increased upon incorporation of puri¢ed Lipid
II. In the presence of Lipid II, the activity of nisin in
dye-leakage assays is in the nM range, the same con-
centration range as the MIC values (E. Breukink et
al. unpublished observations). Thus, Lipid II is the
high a⁄nity target for nisin. Upon interaction with
Lipid II, nisin forms pores in the membrane resulting
in cell death. This nM activity of nisin was achieved
in the absence of a membrane potential. Bearing in
mind that the Lipid II cycle requires energy input, it
seems logical that any disturbance in the energy sta-
tus of the bacterium, e.g. by dissipating the mem-
brane potential, disturbs the Lipid II cycle. Thus,
the lower sensitivity of several bacteria to nisin due
to dissipation of the membrane potential (see Section
3.4 is most likely not the result of a decreased direct
e¡ect of the reduced membrane potential on nisin.
Fig. 8. Model for the central role of Lipid II in the cell wall biosynthesis. See text for details.
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Rather, a reduction in the Lipid II pool causes the
reduced nisin sensitivity of the cells.
4.1. The Lipid II^nisin interaction
Several experiments gave the ¢rst insights into the
structural requirements for the interaction of nisin
with Lipid II. Undecaprenol and undecaprenylphos-
phate had no e¡ect on the nisin activity [46]. Since
nisin binds also to Lipid I [10,46], this suggests that
the ¢rst sugar moiety of Lipid II is important for the
interaction with nisin. Interestingly, nisin displayed
activity against certain Methanobacterium species
[48]. These bacteria contain a cell wall polymer
named ‘pseudomurein’, which resembles the more
common murein of eubacteria in some features.
Namely, it is also build up of two aminosugars,
one of which contains a pentapeptide. The amino
sugars are also transported via Lipid II. However,
the ¢rst sugar of this Lipid II is now GlcNAc not
containing a pentapeptide, while the second sugar is
N-acetyltalosaminuronic acid, to which a pentapep-
tide is attached. The di¡erences between the penta-
peptides are quite large, which suggest that this is not
the binding site for nisin. However, the sugar back-
bones of the ¢rst amino sugar in both Lipid II spe-
cies are quite similar in structure. Therefore, it is
tempting to speculate that this is the recognition
site of nisin. The pyrophosphate and/or the isoprene
moiety are probably also important for the interac-
tion, since recognition of the sugar alone would
mean that the whole cell wall would act as a massive
sink for nisin.
Several experiments suggested that the N-terminus
of nisin is important for the interaction of nisin with
Lipid II. From comparison of the nisin N-terminus
with other lantibiotics that did or did not interact
with Lipid II, it was suggested that the ¢rst two rings
are important for the binding to Lipid II [46]. Sup-
port for this conclusion came from experiments using
nisin variants with modi¢cations in the N-terminus
(I. Wiedemann and H.-G. Sahl, unpublished obser-
vations). An interesting observation in this regard
also arose from experiments using nisin fragments
[49]. Speci¢cally, an N-terminal nisin fragment (resi-
dues 1^12) antagonized the activity of intact nisin
towards L. lactis cells. It is tempting to speculate
that this inhibition was caused by binding of the
N-terminal fragment to Lipid II. Interestingly, the
N-terminal nisin fragment was not able to antago-
nize the activity of subtilin against L. lactis cells. The
N-terminus of subtilin resembles the nisin N-termi-
nus, but has some variations [13]. This suggests that
these variations could have increased the a⁄nity of
subtilin for Lipid II with respect to the nisin a⁄nity
for Lipid II. These results show that the special
structural elements of nisin, the ring structures, are
important for the interaction with Lipid II.
5. Concluding remarks
Nisin is indeed a special case, as it uses a combi-
nation of a high a⁄nity interaction with the mem-
brane anchored Lipid II and pore formation to kill
bacterial cells. It is the combination of these proper-
ties that make nisin such an e¡ective molecule.
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